Malondialdehyde as an indicator of oxidative stress during abdominal aortic aneurysm repair

Angiology

Volumn 58, Issue 4, 2007, Pages 477-482

  Papalambros, Efstathios ^a,d   Sigala, Fragiska ^a   Georgopoulos, Sotiris ^a   Paraskevas, Kosmas I ^b   Andreadou, Ioanna ^c   Menenakos, Xaralambos ^a   Sigalas, Panagiotis ^c   Papalambros, Alexandros L ^a   Vourliotakis, Georgios ^a   Giannopoulos, Athanasios ^a   Bakoyiannis, Christos ^a   Bastounis, Elias ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ATHENS   (Greece)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANESTHESIA; ANEURYSM SURGERY; AORTA CLAMPING; ARTICLE; BLEEDING; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SPECTROPHOTOMETRY;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; OXIDATIVE STRESS; PROGNOSIS; SPECTROPHOTOMETRY; VASCULAR SURGICAL PROCEDURES;

EID: 34548142665     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707305246     Document Type: Article

References (44)

1. Dillavou ED, Muluk SC, Makaroun MS: Improving aneurysm-related outcomes: Nationwide benefits of endovascular repair. J Vasc Surg 43: 446-451, 2006.
2. Filipovic M., Goldacre MJ, Roberts SE,, et al. Trends in mortality and hospital admission rates for abdominal aortic aneurysm in England and Wales, 1979-1999. Br J Surg 92: 968-975, 2005.
3. Hua HT, Cambria RP, Chuang SK,, et al. Early outcomes of endovascular versus open abdominal aortic aneurysm repair in the National Surgical Quality improvement Program-Private Sector (NSQIP-PS). J Vasc Surg 41: 382-389, 2005.
4. Forbes TL, Steiner SH, Lawlor DK,, et al. Risk-adjusted analysis of outcomes following elective open abdominal aortic aneurysm repair. Ann Vasc Surg 19: 142-148, 2005.
5. Norwood MG, Bown MJ, Sayers DP: Ischemia-reperfusion injury and regional inflammatory responses in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 28: 234-245, 2004.
6. Bown MJ, Nicholson ML, Bell PR,, et al. The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair. J Vasc Surg 37: 600-606, 2003.
7. Sullivan GW, Sarembock IJ, Linden J.: The role of inflammation in vascular diseases. J Leukoc Biol 67: 591-602, 2000.
8. Matheus WR, Guido DM, Fisher MA,, et al. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Radic Biol Med 16: 763-770, 1994.
9. Miller FJ Jr, Sharp WJ, Fang X.,, et al. Oxidative stress in human abdominal aortic aneurysms: A potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 22: 560-565, 2002.
10. Lindsay TF, Luo XP, Lehotay DC,, et al. Ruptured abdominal aortic aneurysm, a "two-hit" ischemia/ reperfusion injury: Evidence from an analysis of oxidative products. J Vasc Surg 30: 219-228, 1999.
11. Requena JR, Fu MX, Ahmed MU,, et al. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 11: 48-53, 1996.
12. Andreadou I., Tasouli A., Iliodromitis E.,, et al. Reduction of myocardial infarct size in rabbits by a novel indole derivative with antioxidant and free radical scavenging properties. Eur J Pharmacol 453: 271-277, 2002.
13. Miwa K., Igawa A., Nakagawa K.,, et al. Consumption of vitamin E in coronary circulation in patients with variant angina. Cardiovasc Res 41: 291-298, 1999.
14. Kugiyama K., Miyao Y., Sakamoto T.,, et al. Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. Am J Physiol Heart Circ Physiol 280: H264 - H271, 2001.
15. Andreadou I., Iliodromitis EK, Mikros E.,, et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 237: 500-510, 2004.
16. Cavalca V., Cighetti G., Bamonti F.,, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 47: 887-892, 2001.
17. Bastounis E., Filis K., Georgopoulos A.,, et al. Selective use of the intensive care unit after elective infrarenal abdominal aortic aneurysm repair. Int Angiol 22: 308-316, 2003.
18. Shah PK: Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96: 2115-2117, 1997.
19. Freestone T., Turner RJ, Coady A.,, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15: 1145-1151, 1995.
20. Dubick MA, Keen CL, DiSilvestro RA,, et al. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 220: 39-45, 1999.
21. Briede JJ, De Kok TM, Hogervorst JG,, et al. Development and application of an electron spin resonance spectrometry method for the determination of the oxygen free radical formation by particulate matter. Environ Sci Technol 39: 8420-8426, 2005.
22. Templar J., Kon SP, Milligan TP,, et al. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 14: 946-951, 1999.
23. Vainas T., Lubbers T., Stassen FR,, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107: 1103-1110, 2003.
24. Lawrence DM, Singh RS, Franklin DP,, et al. Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg 40: 334-338, 2004.
25. Pan JH, Lindholt JS, Sukhova GK,, et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg 237: 628-635, 2003.
26. Adembri C., Kastamoniti E., Bertolozzi I.,, et al. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med 32: 1170-1177, 2004.
27. Fantini GA, Conte MS: Pulmonary failure following lower torso ischemia: Clinical evidence for a remote effect of reperfusion injury. Am Surg 61: 316-319, 1995.
28. Roumen RM, Hendriks T., de Man BM,, et al. Serum lipofuscin as a prognostic indicator of adult respiratory distress syndrome and multiple organ failure. Br J Surg 81: 1300-1305, 1994.
29. Wijnen MH, Roumen Rmh, Vader HL,, et al. A multi-antioxidant supplementation reduces damage from ischaemia reperfusion in patients after lower torso ischaemia: A randomised trial. Eur J Vasc Endovasc Surg 23: 486-490, 2002.
30. Poder P., Pulges A., Kals J.,, et al. Is elective abdominal aortic aneurysm repair accompanied by high grade oxidative stress? Scand J Surg 92: 206-209, 2003.
31. Pararajasingam R., Wieght SC, Bell PR,, et al. Pulmonary nitric oxide metabolism following infrarenal aortic cross-clamp-induced ischemia-reperfusion injury. Eur J Vasc Endovasc Surg 19: 47-51, 2000.
32. Liu SX, Hou FF, Guo ZJ,, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26: 1156-1162, 2006.
33. Barry MC, Kelly CJ, Abdih H.,, et al. Differential effects of lower limb revascularisation on organ injury and the role of the amino acid taurine. Eur J Vasc Endovasc Surg 13: 193-201, 1997.
34. Athyros VG, Mikhailidis DP, Didangelos,, et al. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: A randomised study. Curr Med Res Opin 22: 873-883, 2006.
35. Tsiara S., Elisaf M., Mikhailidis DP: Early vascular benefits of statins. Curr Med Res Opin 19: 540-546, 2003.
36. Alnaeb ME, Youssef M., Mikhailidis DP,, et al. Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease. Angiology 57: 65-71, 2006.
37. Lee JD, Morrissey JR, Mikhailidis DP,, et al. CARDS on the table: Should everybody with type 2 diabetes take a statin? Curr Med Res Opin 21: 357-362, 2005.
38. Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP,, et al. A review of the lipid related effects of fluvastatin. Curr Med Res Opin 21: 231-244, 2005.
39. Suzuki M., Saito M., Nagai T.,, et al. Prevention of positive coronary artery remodelling with statin therapy in patients with coronary artery disease. Angiology 57: 259-265, 2006.
40. Reddy R., Chahoud G., Mehta JL: Modulation of cardiovascular remodelling with statins: fact or fiction? Curr Vasc Pharmacol 3: 67-79, 2005.
41. Paraskevas KI, Liapis CD, Hamilton G.,, et al. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 32: 286-293, 2006.
42. Leurs LJ, Visser P., Laheij RJ,, et al. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 14: 1-8, 2006.
43. Lloyd GM, Newton JD, Norwood MG,, et al. Patients with abdominal aortic aneurysms: Are we missing the opportunity for cardiovascular risk reduction? J Vasc Surg 40: 691-697, 2004.
44. Kertai MD, Boersma E., Westerhout CM,, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28: 343-352, 2004.